argenx
The CMC Development Lead builds and defines the long-term CMC strategy for specific assets, ensuring alignment with the Target Product Profile and clinical development plans. This role provides leadership to the CMC Development team, facilitating communication between the Asset Strategy Team and technical operations. The position requires overseeing end-to-end CMC activities, including drug substance and product manufacturing, while supporting due diligence for external programs.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2008
Reaching Patients Through Immunology Innovation
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for argenx.
OMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago